2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Uterine Cervical Neoplasms
1
Shock, Septic
1
Sepsis
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Anti-Bacterial Agents
2
ziprasidone
1
telavancin
1
soybean oil, phospholipid emulsion
1
drotrecogin alfa activated
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
Simvastatin
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Povidone-Iodine
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Multiplex Polymerase Chain Reaction
1
Molindone
1
Methylprednisolone
1
Methods
1
Meropenem
1
Massage
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sepsis
×
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
×
Clear all
NCT00930085
2011-09-14
PROTEOHSEPS
Institut Paoli-Calmettes
Phase NA
Completed
60 enrolled